Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Neuropeptides in Alzheimer type dementia.

I N Ferrier, A J Cross, J A Johnson

    Journal of the Neurological Sciences
    |December 1, 1983
    PubMed
    Summary

    In Alzheimer-type dementia, somatostatin (SRIF) levels decreased in cortical areas, unlike other neuropeptides. These SRIF changes did not consistently correlate with neuropathology or choline acetyltransferase deficits.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The European Prospective Investigation into Cancer and Nutrition Cohort (EPIC): a gateway to rare cancer epidemiological research.

    ESMO rare cancers·2025
    Same author

    The role of physical activity, sedentary behaviour, diet, adiposity and body composition on health-related quality of life and cancer-related fatigue after diagnosis of colorectal cancer: a Global Cancer Update Programme (CUP Global) systematic literature review and meta-analysis.

    ESMO open·2025
    Same author

    Supraphysiological vitamin B12 serum concentrations without supplementation: the pitfalls of interpretation.

    QJM : monthly journal of the Association of Physicians·2019
    Same author

    Meeting report from the joint IARC-NCI international cancer seminar series: a focus on colorectal cancer.

    Annals of oncology : official journal of the European Society for Medical Oncology·2019
    Same author

    Use of intravenous immunoglobulin for the treatment of autoimmune encephalitis: audit of the NHS experience.

    JRSM open·2018
    Same author

    Altered expression of histamine signaling genes in autism spectrum disorder.

    Translational psychiatry·2017

    Area of Science:

    • Neuroscience
    • Neuropathology
    • Biochemistry

    Background:

    • Alzheimer-type dementia (ATD) is characterized by neuropathological changes and neurotransmitter system alterations.
    • Investigating neuropeptide changes in ATD is crucial for understanding disease mechanisms.

    Purpose of the Study:

    • To measure levels of five neuropeptides (cholecystokinin, vasoactive intestinal polypeptide, somatostatin, neurotensin, and substance P) in various brain regions of individuals with and without ATD.
    • To assess choline acetyltransferase (CAT) activity in relation to neuropeptide changes.

    Main Methods:

    • Neuropeptide levels were quantified in 14 brain areas from 12 ATD brains and 13 control brains.
    • Choline acetyltransferase (CAT) activity was measured in 6 brain areas.
    • Statistical analysis was performed to compare peptide levels and CAT activity between groups and identify correlations.

    Related Experiment Videos

    Main Results:

    • Somatostatin (SRIF) levels were reduced in several cortical areas in ATD, but not in hippocampus, amygdala, thalamus, hypothalamus, or most striatal areas.
    • SRIF reduction in ATD was less widespread and severe than CAT activity deficits.
    • An increase in substance P (SP) was observed in the putamen, and altered NT and SRIF levels were found in the septum in ATD.

    Conclusions:

    • Somatostatin (SRIF) is the primary neuropeptide showing significant changes in Alzheimer-type dementia, mainly in cortical regions.
    • These SRIF alterations do not uniformly mirror neuropathological changes or CAT deficits.
    • The findings suggest a complex interplay of neurotransmitter and neuropeptide dysregulation in ATD.